X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6129) 6129
Newsletter (12) 12
Publication (11) 11
Book Chapter (10) 10
Dissertation (7) 7
Magazine Article (6) 6
Newspaper Article (3) 3
Conference Proceeding (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4984) 4984
female (3962) 3962
science & technology (3844) 3844
life sciences & biomedicine (3687) 3687
epirubicin - administration & dosage (3421) 3421
middle aged (3236) 3236
antineoplastic combined chemotherapy protocols - therapeutic use (2676) 2676
adult (2614) 2614
aged (2593) 2593
oncology (2568) 2568
epirubicin (2190) 2190
male (2011) 2011
breast neoplasms - drug therapy (1802) 1802
chemotherapy (1326) 1326
cyclophosphamide - administration & dosage (1244) 1244
fluorouracil - administration & dosage (1220) 1220
treatment outcome (1186) 1186
breast cancer (1156) 1156
antineoplastic combined chemotherapy protocols - adverse effects (1064) 1064
epirubicin - adverse effects (1007) 1007
breast neoplasms - pathology (972) 972
cancer (929) 929
epirubicin - therapeutic use (907) 907
antineoplastic combined chemotherapy protocols - administration & dosage (847) 847
cisplatin - administration & dosage (816) 816
chemotherapy, adjuvant (731) 731
anthracyclines (684) 684
drug administration schedule (675) 675
neoplasm staging (675) 675
disease-free survival (624) 624
combined modality therapy (612) 612
prognosis (597) 597
survival rate (586) 586
doxorubicin - administration & dosage (584) 584
antibiotics, antineoplastic - administration & dosage (543) 543
animals (507) 507
pharmacology & pharmacy (493) 493
follow-up studies (488) 488
epirubicin - pharmacology (487) 487
paclitaxel - administration & dosage (473) 473
survival analysis (469) 469
retrospective studies (431) 431
prospective studies (427) 427
dose-response relationship, drug (416) 416
neoadjuvant therapy (416) 416
medicine & public health (404) 404
aged, 80 and over (398) 398
care and treatment (392) 392
breast neoplasms - surgery (378) 378
taxoids - administration & dosage (373) 373
cyclophosphamide (368) 368
time factors (331) 331
cyclophosphamide - adverse effects (330) 330
adenocarcinoma - drug therapy (322) 322
breast neoplasms - mortality (315) 315
antibiotics, antineoplastic - therapeutic use (309) 309
methotrexate - administration & dosage (308) 308
surgery (307) 307
stomach neoplasms - drug therapy (304) 304
research (302) 302
adolescent (296) 296
cisplatin (286) 286
doxorubicin (286) 286
neoplasm metastasis (285) 285
docetaxel (277) 277
analysis (276) 276
etoposide - administration & dosage (274) 274
cell line, tumor (272) 272
fluorouracil - adverse effects (272) 272
deoxycytidine - analogs & derivatives (271) 271
doxorubicin - therapeutic use (271) 271
cyclophosphamide - therapeutic use (269) 269
paclitaxel (265) 265
doxorubicin - adverse effects (264) 264
liver neoplasms - drug therapy (264) 264
antibiotics, antineoplastic - adverse effects (262) 262
antineoplastic agents - therapeutic use (262) 262
vincristine - administration & dosage (258) 258
drug therapy (257) 257
remission induction (257) 257
mice (248) 248
tumors (247) 247
lymphatic metastasis (244) 244
lung neoplasms - drug therapy (243) 243
risk factors (238) 238
urinary bladder neoplasms - drug therapy (238) 238
health aspects (236) 236
fluorouracil - therapeutic use (233) 233
liver neoplasms - therapy (233) 233
breast neoplasms - metabolism (232) 232
hematology (231) 231
deoxycytidine - administration & dosage (229) 229
epirubicin - pharmacokinetics (226) 226
neoadjuvant chemotherapy (226) 226
carboplatin - administration & dosage (222) 222
abridged index medicus (220) 220
adjuvant treatment (217) 217
antineoplastic agents - administration & dosage (214) 214
infusions, intra-arterial (214) 214
mitomycin - administration & dosage (214) 214
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5616) 5616
Japanese (383) 383
Chinese (156) 156
German (95) 95
French (65) 65
Italian (54) 54
Spanish (31) 31
Russian (24) 24
Polish (18) 18
Hungarian (13) 13
Korean (8) 8
Portuguese (7) 7
Bulgarian (5) 5
Romanian (4) 4
Danish (3) 3
Serbian (3) 3
Turkish (3) 3
Czech (2) 2
Croatian (1) 1
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of controlled release, ISSN 0168-3659, 11/2015, Volume 218, pp. 36 - 44
Journal Article
The lancet oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1467 - 1482
Rilotumumab is a fully human monoclonal antibody that selectively targets the ligand of the MET receptor, hepatocyte growth factor (HGF). We aimed to assess... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Capecitabine - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - administration & dosage | Esophageal Neoplasms - mortality | Adult | Stomach Neoplasms - genetics | Antibodies, Monoclonal, Humanized - adverse effects | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagogastric Junction - pathology | Proto-Oncogene Proteins c-met - drug effects | Treatment Outcome | Stomach Neoplasms - drug therapy | Proto-Oncogene Proteins c-met - genetics | Disease-Free Survival | Capecitabine - adverse effects | Esophageal Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Survival Analysis | Cisplatin - adverse effects | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Epirubicin - adverse effects | Clinical trials | Monoclonal antibodies | Anthracyclines | Product development | Esophageal cancer | Analysis | Index Medicus
Journal Article
Journal Article
Journal Article
Cancer chemotherapy and pharmacology, ISSN 1432-0843, 03/2010, Volume 67, Issue 1, pp. 93 - 101
Journal Article
Cancer science, ISSN 1347-9032, 05/2015, Volume 106, Issue 5, pp. 627 - 634
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 11/2013, Volume 39, Issue 5, pp. 874 - 884
Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates and limited therapeutic options in addition to organ... 
Life Sciences & Biomedicine | Immunology | Science & Technology | Whole-Body Irradiation | Sepsis - prevention & control | Cecum - injuries | Shock, Septic - prevention & control | Epirubicin - administration & dosage | Anti-Bacterial Agents - therapeutic use | Inflammation Mediators - analysis | Anthracyclines - pharmacology | Peritonitis - genetics | Lung - metabolism | Microtubule-Associated Proteins - deficiency | Thienamycins - therapeutic use | Peritonitis - etiology | DNA Repair - drug effects | Mice, Inbred C57BL | Injections, Intraperitoneal | Adenoviridae Infections - immunology | Inflammation | Peritonitis - immunology | Organ Specificity | Ataxia Telangiectasia Mutated Proteins - physiology | Microtubule-Associated Proteins - physiology | Autophagy-Related Protein 7 | Animals | Lung - drug effects | Respiratory Tract Infections - immunology | Epirubicin - therapeutic use | Peritonitis - physiopathology | Anti-Bacterial Agents - pharmacology | Ataxia Telangiectasia Mutated Proteins - deficiency | Fanconi Anemia Complementation Group D2 Protein - physiology | Mice | Anthracyclines - therapeutic use | DNA Damage | Peritonitis - drug therapy | Epirubicin - pharmacology | Anthracyclines | DNA repair | DNA damage | DNA | Flow cytometry | Antibiotics | Mortality | Sepsis | Infections | Viral infections | Deoxyribonucleic acid--DNA | Index Medicus | ATM | Autophagy
Journal Article
9.